Rushed through last minute before parliament is dissolved using emergency powers.

Should’ve been debated in the commons at least.

  • streetlightsOP
    link
    English
    -26 months ago

    They aren’t banned for use as a treatment for precocious puberty, which presumably is something anyone can suffer from trans or otherwise.

    • @[email protected]
      link
      fedilink
      English
      0
      edit-2
      6 months ago

      Yeah but they’re banned for use for kids who suffer from gender dysphoria, which is a condition that by definition only trans kids have, so it’s absolutely restricting access to them exclusively for trans kids, and to rub salt in on the wound, the use of what the government calls “dangerous” (and TERFs who dictate policy and the media line call “experimental” and “untested” and fearmonger about non-existent negative side effects) will continue on cis kids, because their lives and their struggles are seen as worth more than the trans kids’, as was already evident to trans folks, with how the fearmongering about hypothetical harm to >1% of trans people who detransition conveniently forgets about those 99% who would - and often already do today - suffer very real harm from treatment withheld.

      • streetlightsOP
        link
        English
        -16 months ago

        They aren’t banned for kids who suffer from dysphoria. They are banned from being used as a treatment for dysphoria. Important difference.

        • @[email protected]
          link
          fedilink
          English
          06 months ago

          That is a pointless difference in practice, because kids who suffer from gender dysphoria would use these meds for treatment of said dysphoria and do in the rest of the world that follows the expert guidance from WPATH, and now they can’t, and the kids will suffer as a result. But hey at least the transes will be mad innit.

          • streetlightsOP
            link
            English
            16 months ago

            It is not a pointless difference. The use of gonadotropin-releasing hormone (GnRH) agonists have been banned in the UK for the treatment of gender dysphoria. They are of course still available for treating precocious puberty, regardless of how anyone identifies.